- Home
- BGM vs GOF Comparison
BGM vs GOF Comparison
Compare BGM & GOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGM
- GOF
- Stock Information
- Founded
- BGM 2019
- GOF 2006
- Country
- BGM China
- GOF United States
- Employees
- BGM N/A
- GOF N/A
- Industry
- BGM
- GOF Finance/Investors Services
- Sector
- BGM
- GOF Finance
- Exchange
- BGM NYSE
- GOF Nasdaq
- Market Cap
- BGM 2.6B
- GOF 2.4B
- IPO Year
- BGM 2021
- GOF N/A
- Fundamental
- Price
- BGM $8.49
- GOF $14.83
- Analyst Decision
- BGM
- GOF
- Analyst Count
- BGM 0
- GOF 0
- Target Price
- BGM N/A
- GOF N/A
- AVG Volume (30 Days)
- BGM 85.4K
- GOF 789.2K
- Earning Date
- BGM 07-24-2025
- GOF 01-01-0001
- Dividend Yield
- BGM N/A
- GOF 15.42%
- EPS Growth
- BGM N/A
- GOF N/A
- EPS
- BGM N/A
- GOF N/A
- Revenue
- BGM N/A
- GOF N/A
- Revenue This Year
- BGM N/A
- GOF N/A
- Revenue Next Year
- BGM N/A
- GOF N/A
- P/E Ratio
- BGM N/A
- GOF N/A
- Revenue Growth
- BGM N/A
- GOF N/A
- 52 Week Low
- BGM $5.26
- GOF $10.96
- 52 Week High
- BGM $17.17
- GOF $16.76
- Technical
- Relative Strength Index (RSI)
- BGM 37.63
- GOF 45.74
- Support Level
- BGM $9.96
- GOF $14.83
- Resistance Level
- BGM $11.50
- GOF $15.20
- Average True Range (ATR)
- BGM 1.38
- GOF 0.13
- MACD
- BGM -0.06
- GOF -0.02
- Stochastic Oscillator
- BGM 22.17
- GOF 21.87
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
About GOF Guggenheim Strategic Opportunities Fund of Beneficial Interest
Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The investment objective of the firm is to maximize total return through a combination of current income and capital appreciation. The Fund seeks to combine a credit-managed fixed-income portfolio with access to a diversified pool of alternative investments and equity strategies.